The nocebo effect: a clinicians guide

scientific article published on 23 October 2012

The nocebo effect: a clinicians guide is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0004867412464717
P698PubMed publication ID23093053

P50authorMichael BerkQ30504747
P2093author name stringJoão Data-Franco
P2860cites workThe amplification of somatic symptomsQ28292452
No gender differences in placebo responses of patients with major depressive disorderQ31871526
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancerQ33625012
The subjective experience of pain: where expectations become realityQ33943765
Nocebo-induced hyperalgesia during local anesthetic injection.Q34020725
Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study GroupQ34067329
Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headachesQ34158126
Influence of context effects on health outcomes: a systematic review.Q34186909
How the number of learning trials affects placebo and nocebo responsesQ34204013
Presenting risk information--a review of the effects of "framing" and other manipulations on patient outcomes.Q34228750
Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placeboQ34273139
Influence of the behaviour pattern on the nocebo response of healthy volunteersQ34346886
Overt versus covert treatment for pain, anxiety, and Parkinson's diseaseQ34359487
Nonspecific medication side effects and the nocebo phenomenonQ34519096
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.Q34581978
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responsesQ34746177
A collaborative approach to the treatment alliance in bipolar disorderQ35947326
Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effectsQ36375840
A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effectQ37113699
A systematic review of adverse events in placebo groups of anti-migraine clinical trialsQ37603565
Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysisQ37610143
Enhancing medication adherence in patients with bipolar disorderQ37664710
Patient expectancy and post-chemotherapy nausea: a meta-analysisQ37729921
Nocebo in fibromyalgia: meta‐analysis of placebo‐controlled clinical trials and implications for practiceQ37942656
Social Psychologic Factors Affecting the Presentation of Bodily ComplaintsQ39914445
Further evidence for individual differences in placebo responding: an interactionist perspectiveQ40218163
Placebo/nocebo symptom reporting in a sham herbal supplement trialQ40270432
The Nocebo Phenomenon: Concept, Evidence, and Implications for Public HealthQ41609492
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.Q43662938
Placebo and Nocebo Responses, Cortisol, and Circulating Beta-EndorphinQ44595395
Nocebo effects in multiple sclerosis trials: a meta-analysisQ46822234
Increased response to a putative panicogenic nocebo administration in female patients with panic disorderQ49052685
Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?Q50148458
Nonspecific side effects of oral contraceptives: nocebo or noise?Q50654952
Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo responseQ50972827
Headaches and the nocebo effectQ51014201
Gender and the nocebo response following conditioning and expectancyQ51649240
Women encounter ADRs more often than do men.Q51695259
Somatization in the population: from mild bodily misperceptions to disabling symptomsQ51798700
Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrenceQ51893433
The role of learning in nocebo and placebo effectsQ51960960
An experimental analysis of classically conditioned nausea during cancer chemotherapyQ52229404
Psychological factors associated with severe abuse of the Hemodialysis dietQ52293429
Why medication in involuntary treatment may be less effective: The placebo/nocebo effectQ57821117
The impact of personality on the reporting of unfounded symptoms and illnessQ58274274
P433issue7
P921main subjectnoceboQ1332954
P304page(s)617-623
P577publication date2012-10-23
P1433published inAustralian and New Zealand Journal of PsychiatryQ4824838
P1476titleThe nocebo effect: a clinicians guide
P478volume47

Reverse relations

cites work (P2860)
Q36274662Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools
Q38129457Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome.
Q37137286Changes in perception of treatment efficacy are associated to the magnitude of the nocebo effect and to personality traits.
Q38363609Nocebo and the potential harm of 'high risk' labelling: a scoping review
Q30596803Nocebo effect in randomized clinical trials of antidepressants in children and adolescents: systematic review and meta-analysis.
Q90264124Pain Anticipation and Nocebo-Related Responses: A Descriptive Mini-Review of Functional Neuroimaging Studies in Normal Subjects and Precious Hints on Pain Processing in the Context of Neurodegenerative Disorders
Q64062792Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Q92069839The Clinical Implications of Nocebo Effects for Biosimilar Therapy
Q92799625The Other Side of the Coin: Nocebo Effects and Psychotherapy
Q36719631The nocebo effect of drugs
Q47586296The role of depression pharmacogenetic decision support tools in shared decision making.
Q47106974Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect

Search more.